FDA incorporated feedback from the diabetes community in a final guidance document on artificial pancreas systems to allow for more flexibility in the design of clinical trials of the devices.
The Nov. 9 document finalized what had been two distinct draft guidance documents – a December 2011 proposal on clinical trial designs for artificial pancreas systems and a June 2011...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?